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Abstract
Responsible development of any technology, including nanotechnology, requires protecting 
workers, the first people to be exposed to the products of the technology. In the case of 
nanotechnology, this is difficult to achieve because in spite of early evidence raising health and 
safety concerns, there are uncertainties about hazards and risks. The global response to these 
concerns has been the issuance by authoritative agencies of precautionary guidance to strictly 
control exposures to engineered nanomaterials (ENMs). This commentary summarizes discussions 
at the “Symposium on the Health Protection of Nanomaterial Workers” held in Rome (25 and 26 
February 2015). There scientists and practitioners from 11 countries took stock of what is known 
about hazards and risks resulting from exposure to ENMs, confirmed that uncertainties still exist, 
and deliberated on what it would take to conduct a global assessment of how well workers are 
being protected from potentially harmful exposures.
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Control procedures; occupational exposure limits; precautionary guidance; toxicity
For almost two decades that the current generation of ENMs has been in commerce, there 
have been increasing numbers of workers involved in the research, manufacture, production, 
and use of them. There are more than 1600 “nanoenabled” products in commerce, all 
required workers for that to happen (http://www.nanotechproject.org/cpi/). This creation and 
utilization of ENMs occurred ahead of government, employer, and worker knowledge about 
potential hazards. However, based on the concerns about small particles (ultrafines) in air 
pollution epidemiology, known health effects of incidental nanoparticles such as diesel and 
welding fumes, and results of early range-finding animal studies, there was a wave of 
precautionary guidance issued in the mid-2000s by governments, organizations, and 
scientists (Table 1) (Aitken et al., 2004; Ambroise et al., 2006; Antonini et al., 2007; BauA, 
2007; Borm et al., 2006; Castranova 2000; Chalupa et al., 2004; Dockery et al., 1993; 
Donaldson et al., 2005; Environmental Defense Fund, 2007; Garshick et al., 2004; Gwinn & 
Vallyathan, 2006; Hett, 2004; HSE, 2004; Ibald-Mulli et al., 2002; Maynard & Kuempel, 
2005; NIOSH, 2005; Oberdörster & Yu, 1990; Oberdörster et al., 2005; Ostiguy et al., 2006; 
Pietropaoli et al., 2004; Pope et al., 2002, 2004; Royal Society and Royal Academy of 
Engineering, 2004; Safe Work Australia, 2010; Shvedova et al., 2005; Tran et al., 2005). 
This guidance essentially called for strict control of exposure to ENMs until more was 
learned about any actual hazards and adverse health effects. The issue was complicated due 
to the vast heterogeneity of ENMs that can result from the combination of numerous 
physico-chemical properties (e.g. size, shape, composition, crystal structure, surface 
characteristics, and impurities) and the fact that there could be a range of toxic potentials 
associated with this universe of materials. Nonetheless, since airborne ENMs follow the laws 
of aerosol physics, control technologies used for fine dusts and powders and pharmaceuticals 
were believed to be, and ultimately shown to be, effective in controlling exposure (NIOSH, 
2005; Plitzko et al., 2013). In the ensuing years since the early guidance was issued, more 
information on hazards of ENMs was developed but still there are many uncertainties and 
the need for precautionary approaches to exposure control and worker protection is still 
warranted (Schulte et al., 2014).
Regarding the protection of the nanomaterial workforce, it is one thing to know what to do, 
it is another to know whether it is being done. A core element of public health in general, 
and occupational health in particular, is the evaluation of the use of recommended control 
procedures (Hanlon, 1974; Levy & Wegman, 1983). The evaluation of the nanomaterial 
workforce protection involves surveillance of hazards and controls to answer the question 
“Are employers worldwide following the precautionary guidance of authoritative 
organizations and strictly controlling exposure to engineered nanomaterials?”
The answer to the question is complicated by the fact that nanotechnology is a decentralized 
enabling technology. There is no nanotechnology industry, but there are many applications 
that occur in companies throughout the world. The challenge is how to obtain information 
on which companies are producing, manufacturing, and using nanomaterials in a manner 
Schulte et al. Page 2













that could lead the generation of airborne nanomaterials in the breathing zone of workers. 
Some preliminary information from the U.S. based on a National Institute for Occupational 
Health (NIOSH) survey showed that in a subset of companies producing carbon nanotubes 
(CNTs) and other nanomaterials, there was 80% (95% CI: 63–92%) using respirators 
(Schubauer-Berigan et al., 2015). While this is not the most preferred control approach, it 
showed some indication of these companies following precautionary guidance. However, the 
extent to which the participants in the investigations were representative of all companies is 
unknown. Also, the extent to which respirators were used indicated a lack of following the 
hierarchy of controls which is the widely recommended approach for controlling 
occupational hazards (NIOSH, 2005; Plog & Quinlan, 2002). The hierarchy of controls 
includes elimination, substitution, engineering controls, administrative controls, and 
personal protection equipment (Schulte et al., 2008). In contrast, published exploratory 
studies from various countries showed relatively high levels of exposure to engineered 
nanomaterials measured in a variety of workplaces (Pietroiusti & Magrini, 2014). Therefore, 
it is still of great importance to identify globally the adherence to precautionary guidance to 
protect workers. To this end, a multistep process was initiated. The first step was the 
development by NIOSH of a survey instrument to assess adherence to precautionary controls 
and guidance. This instrument was developed and received public review (Federal Register, 
2013). However, to apply it to the full complement of workplaces in the U.S. or globally is a 
difficult and expensive task because of the number and diversity of workplaces and potential 
reticence of employers to participate. The number and the location of workers exposed to 
ENMs in these workplaces are difficult to identify. Many companies that use nanomaterials 
do not identify themselves as such. Rather, nanotechnology is a part of their range of 
capabilities, or they identify themselves as producing “advanced materials”. Figure 1 shows 
the dilemma in trying to estimate the number of workers and their locations. Using the 
number of “nanoenabled” products (as derived by Project on Emerging Technologies at the 
Woodrow Wilson International Center for Scholars (http://www.nanotechproject.org)) as a 
surrogate for workers or locations, Figure 1 shows an increase in the slope of the trend 
(through 2020 and a straight line projection beyond). However, the number of workers or 
locations associated with each product is not known, could it be 10, 100, 1000, or 10 000? 
There is also a vast number of ENMs in or that potentially could be in commerce. Finding 
the locations where nanomaterials are manufactured and used is difficult not only for 
assessing adherence to precautionary guidance but also for identifying cohorts of similarly 
exposed workers for epidemiological investigations (Schmid et al., 2009; Schulte et al., 
2009; Riediker et al., 2012).
To further attempt to characterize the use of precautions globally, the International 
Commission on Occupational Health (ICOH), Scientific Committee on Nanomaterial 
Workers Health, proposed a global assessment as part of a work plan developed in 2012 and 
then held an international symposium in Rome in February 2015 on the health protection of 
nanomaterial workers. The symposium “Symposium on the Health Protection of 
Nanomaterial Workers” identified the state of knowledge about nanomaterial hazards, risks, 
and risk management as a prelude to developing a study to assess global adherence to 
precautionary guidance to control exposures to ENMs. This commentary is a summary of 
the discussions at the symposium.
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 Overview of the state of knowledge to protect workers
Figure 2 illustrates the cycle of steps to protect workers. It shows the worker protection is a 
multi-level and multifactorial effort. While research is a driver of the cycle in that it provides 
new information on hazards, another is risk management. Employers need to know what to 
do to protect workers even in the face of uncertainty. Two general approaches have been 
utilized to develop guidance (Figure 3) (Schulte et al., 2010). One involves the case where 
there are adequate physico-chemical and toxicity data. This can lead to specific guidance 
and occupational exposure limits such as those developed for CNTs (NIOSH, 2013). The 
other approach is where there is limited information on one substance or categories of 
substances and various pragmatic approaches are used. This is illustrated by the British 
Standards Institute (BSI) and NanoReference Values developed by the Dutch and Germans 
efforts and various risk-based grouping approaches (BSI, 2007; CEN, 2012; IFA, 2009; 
SER, 2009).
Underpinning the development of occupational exposure limits (OELs) and enterprise-level 
risk management is the need for appropriate exposure assessment. Exposure assessment is 
central for risk assessment since risk is a product of hazard and exposure. Exposure 
assessment is also necessary to inform the employer if the protective risk management 
activities are sufficient and if any relevant threshold limits are complied with. In threshold 
limit compliance, control data must be of sufficient quality as described, for example, in BS-
EN-482 (2012) for Europe (CEN, 2012). This means that an appropriate time-base 
comparable with the threshold limit (i.e., normally 8 h shift or short-term 15 min) is 
necessary. An example of a standard protocol for exposure assessment is the NanoGem (a 
German-funded project on nanosafety, exposure, and risk (Asbach et al., 2015). A critical 
issue in measuring engineered nanomaterial exposure in the air is to determine if the 
measured exposure is significantly above background. Background emissions from 
equipment and sources in the workplace as well as from external environmental sources not 
related to ENMs can confound measurements. Many of these background emissions come 
from diesel engines, electric motors, and air pollution. Generally, they are carbonaceous 
(Dahm et al., 2015; Schauer, 2003). Background nanoparticles may be health hazards and 
should be considered in risk assessments of workplaces where ENM exposures are the focus. 
Figure 4 illustrates the various generic components of nanomaterial (nanoparticles) exposure 
in the workplace.
One approach that may be useful to supplement exposure assessment is biological 
monitoring of nanomaterial workers (Bergamaschi et al., 2015; Erdely et al., 2011; Iavicoli 
et al., 2014). Biological monitoring such as assessing lead in blood in exposed workers is a 
tool with a long history in occupational health. There are various reasons for the expansion 
of biological monitoring in recent years, mainly due to its extensive use in occupational 
health risk assessment (Manno et al., 2010). One reason is represented by the development 
and the validation of new biomarkers of exposure. There is growing literature on the 
identification and measurement of ENMs in biological matrices, although methods are still 
rather complex and expensive (Iavicoli et al., 2014). Another reason in favor of 
biomonitoring is the discovery of increasingly sensitive and/or specific biomarkers of effect, 
which may be quite useful in assessing workers’ early responses to exposure. Available data 
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obtained from laboratory animals and exposed workers suggest that biomarkers of effect 
particularly for oxidative stress, inflammation but also genotoxicity, are useful in 
biomonitoring workers exposed to nanomaterials (Bergamaschi et al., 2015; Nel et al., 
2006). This foundational research may also be informed by the use of “omics” technologies 
to screen ENMs in in vitro studies before they enter commerce (Iavicoli et al., 2014). Also 
important in assessing biomarkers of exposure and effect is the need to consider 
susceptibility factors which may modulate toxicokinetic and toxicodynamic processes 
(Iavicoli et al., 2016). Despite these advances, there is still a need to be able to distinguish 
ENMs from background and to fully validate biomarkers targeted in biological monitoring. 
This validation effort may take many years (Schulte & Hauser, 2012)
An adequate exposure assessment should be complemented by an efficient hazard 
surveillance. To this aim, employers or governments should identify where nanomaterials 
are handled in an enterprise or in groups of enterprises. One pioneering example of hazard 
surveillance on a national level is the EpiNano Program in France (Guseva Canu et al., 
2013). The focus is carbon nanotubes and titanium dioxide nano-objects. Regulation in 
France requires declaration by enterprises where these materials occur. Then if workers in 
the enterprise are identified and registered into the EpiNano Program, they become part of 
an ongoing epidemiologic surveillance research effort.
The efforts of Bundesanstalt für Arbeitsschutz und Arbeitsmedizin (BAuA) surveys in 
Germany, presented at the symposium, illustrate the issues that will probably be seen 
globally in assessing adherence to precautions. In Germany, 1750 companies and research 
institutes were invited to participate in a survey (Plitzko et al., 2013); only 450 responded so 
the low (26%) response rate show a limited representativeness; 76% of respondents were 
from industry and 23% from research. The survey also showed that 63% of the responders 
were in companies with less than 10 employees working with ENMs. Also, the potential 
exposure is rather recent; 46% of responders had been handling nanomaterials for 5 years or 
less. This is a clear indication of rapid development in this field. The main activities 
involving nanomaterials were mixing, dispersing, filling, bagging, feeding, and decanting; 
81% of responders said they used “safety” measures (otherwise undefined), 16% said they 
needed no such measures; 75% reported no need for additional regulation but 24% wanted 
more specific guidance.
 From research to practice
Ultimately, the protection of nanomaterial workers will depend on the utility and application 
of guidance (which could include control or risk assessment information) for employers. 
Because of the global nature of the use of nanotechnology, the World Health Organization 
(WHO) is developing guidelines to assess appropriate health protection activities for 
nanomaterial workers. The approach WHO is taking is to follow the evidence assessment 
involving systematic review and utilizing the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) System (Kortum, 2015). The aim of WHO 
guidelines is to facilitate improvements in occupational health and safety of 
nanotechnologies in a broad range of manufacturing and social environments. The target 
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group in the first phase are policy-makers in low- and medium-income countries whereas in 
the second phase, there will be an implementation guide for employers and workers.
Beyond guidelines, regulation plays a part in worker protection. The NANoREG project is a 
European approach for safety testing of manufactured nanomaterials. It includes 59 partners 
from 14 European countries and involves collaboration between authorities, industry, and 
scientists (Figure 5) to obtain the knowledge required for appropriate risk management and 
to create the basis for common approaches, mutually acceptable datasets, and harmonized 
risk management practices.
A major area of concern in assessing adherence to precautionary guidance is evaluating the 
experiences in transitional and developing countries. These countries are often dependent on 
information and guidance developed elsewhere. They have, however, a rich diversity of 
workplaces ranging from early industrial to “high tech”. The experience in Argentina 
illustrates approaches that are useful. Generally, the focus has been on small companies, 
with an emphasis on containment, ventilation, good practices, and personal protective 
equipment (PPE). The control banding Nanotool is one instrument that has been used as was 
the DuPont-EDF NanoRisk Framework, and NIOSH “Approaches to Safe Nanotechnology” 
(Environmental Defense Fund, 2007; NIOSH, 2005).
Another issue when considering nanotechnology and workers’ health is that nanotechnology 
crosses other key enabling technologies such as microelectronics, photonics, 
biotechnologies, advanced materials, and advanced manufacturing systems. 
Nanotechnologies indicate new ways of manufacturing encompassing all industrial sectors 
and the entire value chain. Cross-cutting nanotechnology is the Responsible Research and 
Innovation concept that globally has been promoted in response to the rising demand for 
sustainable growth. It includes corporate social responsibility (CSR) and environmental 
safety and health (ESH). Critical for including occupational safety and health (OSH) in new 
technologies is an active “research to practice” effort. Such transfer will be better 
accomplished by harmonized methods and collaboration among organizations. Choosing the 
right way to the future is becoming more demanding. Scientific knowledge and practical 
experience are the best tools for navigation (Rantanen, 2008). Focusing on safety earlier in 
the innovation process is critical for responsible development of a technology. This new 
focus is illustrated in Figure 5. A technology is not being developed responsibly if workers 
are not protected (Schulte et al., 2014).
 Global assessment of the adherence to precautionary guidance
The objectives of a global assessment are to generate an up-to-date picture of the global 
nanowork situation, to identify the exposure panorama qualitatively if not quantitatively, to 
identify hotspots in need of information and interventions, and to generate knowledge for 
subsequent action plans. The development and administration of such an assessment is a 
major effort. The value of ICOH directing the assessment is that it has a global occupational 
safety and health focus.
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The development and administration of such a survey is a major effort. The ICOH scientific 
committee is in the process of soliciting parties to assist in the survey by planning, funding, 
and administering it. Potential collaborators could be WHO, the WHO Collaborating Center 
Network, International Labor Organization (ILO), and other international associations and 
corporations. A three tier approach was envisioned at the Rome Symposium. It included (1) 
collection and analysis of relevant studies, e.g., NIOSH (Schubauer-Berigan et al., 2015), 
(BAuA, EpiNano) (BauA, 2007; Guseva Canu et al., 2013; Guseva Canu et al., 2015), (2) 
development and early testing of a questionnaire in a pilot study, and (3) the global 
assessment. Various operational questions still need resolution. These include identifying a 
sampling frame, determining how to maintain confidentiality of data, maximizing the 
motivation for participation, and funding.
A key rationale for participating in the survey is that the responsible development of a new 
technology, such as nanotechnology, cannot be achieved if workers are harmed by it. During 
the early utilization of the technology when uncertainty about hazards and risks is high, it is 
part of responsible development to assure that precautions are being (Schulte et al., 2014). 
Business, government, labor, and other organizations must invest in developing and 
coordinating such evaluations.
In summary, there are still major uncertainties about the toxic potential of engineered 
nanomaterials. Consequently, the precautionary guidance issued by various authoritative 
organizations globally still is pertinent. The participants at the symposium concluded that 
part of whether nanotechnology is being developed responsibly is determining the extent to 
which precautionary guidance is being followed. The ICOH assessment of adherence to this 
guidance is a missing piece in occupational safety and efforts to protect the nanomaterial 
workforce.
 Acknowledgments
The authors wish to acknowledge Dr. Evelyn Kortum (WHO) who presented at the symposium. The authors would 
also like to thank Candace Tsai, Maurizio Manno, and Michael Riediker for their comments on early drafts of this 
manuscript.
References
Aitken, R.; Creely, K.; Tran, C. Nanoparticles: An Occupational Hygiene Review. Norwich, UK: HSE 
Books; 2004. 
Ambroise D, Wild P, Moulin JJ. Update of a meta-analysis on lung cancer and welding. Scand J Work 
Environ Health. 2006; 32:22–31. [PubMed: 16539169] 
Antonini JM, Stone S, Roberts JR, Chen B, Schwegler-Berry D, Afshari AA, Frazer DG. Effect of 
short-term stainless steel welding fume inhalation exposure on lung inflammation, injury, and 
defense responses in rats. Toxicol Appl Pharmacol. 2007; 223:234–45. [PubMed: 17706736] 
Asbach, C.; Kuhlbusch, T.; Stahlmecke, B.; Kaminski, H.; Kiesling, M.; Voetz, M., et al. Measurement 
and monitoring strategy for assessing workplace exposure to airborne nanomaterials. In: Wohlleben, 
W.; Kuhlbusch, T.; Lehr, C.; Schnekenburger, J., editors. Safety of Nanomaterials along their 
Lifecycle: Release, Exposure and Human Hazard. New York: Taylor and Francis; 2015. p. 233-46.
BAuA (BundesanstaltfürArbeitsschutzundArbeitsmedizin). Guidance for handling and use of 
nanomaterials at the workplace. 2007. Available at: http://www.baua.de/en/Topics-from-A-to-Z/
Hazardous-Substances/Nanotechnology/pdf/guidance.pdf?__blob=publicationFile&v=2
Schulte et al. Page 7













Bergamaschi E, Poland C, Guseva Canu I, Prina-Mello A. The role of biological monitoring in nano-
safety. Nano Today. 2015; 10:274–77.
Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, et al. The potential risks of 
nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol. 2006; 3:11.doi: 
10.1186/1746-8977-3-11 [PubMed: 16907977] 
BSI. Guide to Safe Handling and Disposal of Manufactured Nanomaterials. London: British Standard 
Institution PD 6699-2; 2007. p. 32
Castranova V. From coal mine dust to quartz: mechanisms of pulmonary pathogenicity. Inhal Toxicol. 
2000; 12:7–14. [PubMed: 26368596] 
CEN (de Comité Normalisation Européen). EN482 Workplace Exposure – General Requirements for 
the Performance of Procedures for the Measurement of Chemical Agents. Brussels, Belgium: 
Comité Européende Normalisation (CEN); 2012. 
Chalupa DC, Morrow PE, Oberdörster G, Utell MJ, Frampton MW. Ultrafine particle deposition in 
subjects with asthma. Environ Health Perspect. 2004; 112:879. [PubMed: 15175176] 
Dahm MM, Schubauer-Berigan MK, Evans DE, Birch ME, Fernback JE, Deddens JA. Carbon 
nanotube and nanofiber exposure assessments: an analysis of 14 site visits. Ann Occup Hyg. 2015; 
6:705–23. [PubMed: 25851309] 
Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air 
pollution and mortality in six US cities. N Engl J Med. 1993; 329:1753–9. [PubMed: 8179653] 
Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, et al. Combustion-derived 
nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol. 2005; 
2:10–4. [PubMed: 16242040] 
Environmental Defense Fund. Nanorisk framework. DuPont. 2007. Available at: http://
qsinano.com/wp-content/uploads/2014/05/nano_risk_framework_dupont.pdf. Accessed on 5 
January 2016
Erdely A, Liston A, Salmen-Muniz R, Hulderman T, Young SH, Zeidler-Erdely PC, et al. 
Identification of systemic markers from a pulmonary carbon nanotube exposure. J Occup Environ 
Med. 2011; 53:S80–6. [PubMed: 21654424] 
Federal Register. Survey of Nanomaterial Risk Management Practices. Vol. 78. Washington, DC: 
Federal Register; 2013. 
Garshick E, Laden F, Hart JE, Rosner B, Smith TJ, Dockery DW, Speizer FE. Lung cancer in railroad 
workers exposed to diesel exhaust. Environ Health Perspect. 2004; 112:1539–43. [PubMed: 
15531439] 
Guseva Canu I, Boutou-Kempf O, Delabre L, Ducamp S, Iwatsubo Y, Marchand JL, Imbernon E. 
French registry of workers handling engineered nanomaterials as an instrument of integrated 
system for surveillance and research. J Phys: Conf Series. 2013; 429(1) doi: 
10:1088/1742-6596/429/1/012066. 
Guseva Canu I, Ducros C, Ducamp S, Delabre L, Audignon-Durand S, Durand C, et al. Standardized 
non-instrumental tool for characterizing workstations concerned with exposure to engineered 
nanomaterials. J Phys: Conf Serv. 2015; 617doi: 10.1088/1742-6596/617/1/012036
Gwinn MR, Vallyathan V. Nanoparticles: health effects-pros and cons. Environ Health Perspect. 2006; 
114:1818–25. [PubMed: 17185269] 
Hanlon, JJ. Public Health Administration and Practice. St. Louis, MO: CV Mosby Company; 1974. 
Hett, A. Nanotechnology: Small Matter, Many Unknowns. Zurich: Swiss Reinsurance Company; 2004. 
HSE. Nanotechnology. Horizons Scanning Information Note No HSIN1. London: Health and Safety 
Executive; 2004. 
Iavicoli I, Leso V, Manno M, Schulte PA. Biomarkers of nanomaterial exposure and effect: current 
status. J Nanopart Res. 2014; 16:1–33.
Iavicoli I, Leso V, Schulte PA. Biomarkers of susceptibility: state of the art and implications for 
occupational exposure to engineered nanomaterials. Toxicol Appl Pharmacol. 2016
Ibald-Mulli A, Wichmann HE, Kreyling W, Peters A. Epidemiological evidence on health effects of 
ultrafine particles. J Aerosol Med. 2002; 15:189–201. [PubMed: 12184869] 
Schulte et al. Page 8













Institut for Arbeitsschutzder Deutschen Gesetzlichen Unfallversicherung (IFA). Criteria for 
Assessment of the Effectiveness of Protective Measures. Germany: IFA; 2009. 
Kortum, E. Developing WHO guidelines for protecting workers from potential risks of manufactured 
nanomaterials. 2015. Available at: http://www.nanotec.or.th/en/wp-content/uploads/2015/09/
WHO-V-Murashov_NANO-HEALT.pdf. Accessed on 5 January 2016
Levy, BS.; Wegman, PH., editors. Occupational Health: Recognizing and Preventing Work-related 
Disease. Boston: Little Brown and Company; 1983. 
Manno M, Viau C, Cocker J, Colosio C, Lowry L, Mutti A, et al. Biomonitoring for occupational 
health risk assessment (BOHRA). Toxicol Lett. 2010; 192:3–16. [PubMed: 19446015] 
Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational health. J Nanopart 
Res. 2005; 7:587–614.
Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006; 311:622–7. 
[PubMed: 16456071] 
NIOSH. Approaches to Safe Nanotechnology: An Information Exchange with NIOSH. Department of 
Health and Human Services, Centers for Disease Control and Prevention, National Institute for 
Occupational Safety and Health; 2005. Available at: http://www.cdc.gov/niosh/topics/nanotech/
pdfs/Approaches_to_Safe_Nanotechnology.pdf. Accessed on 13 August 2013
NIOSH. Current Intelligence Bulletin 65: Occupational Exposure to Carbon Nanotubes and 
Nanofibers. Cincinnati, OH: Department of Health and Human Services, Centers for Disease 
Control and Prevention, National Institute for Occupational Safety and Health; 2013. DHHS 
(NIOSH) Publication 2013-145
Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from 
studies of ultrafine particles. Environ Health Perspect. 2005; 113:823–39. [PubMed: 16002369] 
Oberdörster G, Yu CP. The carcinogenic potential of inhaled diesel exhaust: a particle effect? J Aerosol 
Sci. 1990; 21:S397–401.
Ostiguy, C.; Lapointe, G.; Ménard, L.; Cloutier, Y.; Trottier, M.; Boutin, M., et al. Nanoparticles: 
current knowledge about occupational health and safety risks and prevention measures. Montreal: 
Disponibleen; 2006. Studies and research, IRSST, Report R-470Available at: http://
www.irsst.qc.ca/media/documents/pubirsst/r-470.pdf. Accessed on 5 January 2016
Ostiguy, C.; Roberge, B.; Woods, C.; Soucy, B. Nanoparticles: current knowledge about OSH risks and 
prevention measures. 2nd. Montreal: Disponibleen; 2010. IRSST Report R-656Available at: http://
www.irsst.qc.ca/medica/documents/pubirsst/r-456.pdf.[Links].
Pietroiusti A, Magrini A. Engineered nanoparticles at the workplace: current knowledge about workers 
risk. Occup Med. 2014; 64:319–30.
Pietropaoli, A.; Frampton, M.; Oberdörster, G.; Cox, C.; Huang, L.; Marder, V.; Utell, M. Blood 
markers of coagulation and inflammation in healthy human subjects exposed to carbon ultra fine 
particles. In: Heinrich, U., editor. Effects of Air Contaminants on the Respiratory Tract-
Interpretations from Molecular to Meta Ananlysis. Stuttgart, Germany: Fraunhofer IRB Verlag; 
2004. p. 181-94.INIS Monographs
Plitzko S, Thim C, Bachmann V. Zweite Fragebogenaktion zu Aspekten des Arbeitsschutzes bei der 
Herstellung und bei Tätigkeiten mit Nanomaterialien in Deutschland. Bundesanstalt Für 
Arbeitsschutz Und Arbeitsmedizin. Gefahrstoffe-Reinhaltlung Luft. 2013; 73:7–13.
Plog, BA.; Quinlan, P. Fundamentals of Industrial Hygiene. 5th. Itasa, IL: National Safety Council; 
2002. 
Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, 
cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002; 
287:1132–41. [PubMed: 11879110] 
Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular 
mortality and long-term exposure to particulate air pollution epidemiological evidence of general 
pathophysiological pathways of disease. Circulation. 2004; 109:71–7. [PubMed: 14676145] 
Rantanen, J. Risks in Modern Society. Netherlands: Springer; 2008. Challenges to global governance 
in the changing world of work; p. 17-59.
Schulte et al. Page 9













Riediker M, Schubauer-Berigan MK, Brouwer DH, Nelissen I, Koppen G, Frijns E, et al. A road map 
toward a globally harmonized approach for occupational health surveillance and epidemiology in 
nanomaterial workers. J Occup Environ Med. 2012; 54:1214–23. [PubMed: 22995812] 
Royal Society and Royal Academy of Engineering. Nanoscience and Nanotechnologies: Opportunities 
and Uncertainties. London: Royal Society and Royal Academy of Engineering; 2004. 
Safe Work Australia. Work health and safety assessment tool for handling engineered nanomaterials. 
2010. Available at: http://www.safeworkaustralia.gov.au/sites/swa/about/publications/pages/
at201008workhealthandsafetyassessmenttool. Accessed on 5 January 2016
Schauer JJ. Evaluation of elemental carbon as a marker for diesel particulate matter. J Expo Anal 
Environ Epidemiol. 2003; 13:443–53. [PubMed: 14603345] 
Schmid, A.; Goel, S.; Wang, W.; Beiu, V.; Carrara, S.; Riediker, M. Chances and risk of nanomaterials 
for health and environment. In: Akan, O.; Bellavista, P.; Cao, J.; Dressler, F.; Ferrari, D.; Gerla, 
M., et al., editors. Nature-Net. Vol. 20. Berlin, Heidelberg: Springer; 2009. p. 128-33.
Schubauer-Berigan MK, Dahm MM, Schulte PA, Hodson L, Geraci CL. Characterizing adoption of 
precautionary risk management guidance for nanomaterials, an emerging occupational hazard. J 
Occup Environ Hyg. 2015; 12:69–75. [PubMed: 25093252] 
Schulte PA, Geraci CL, Murashov V, Kuempel ED, Zumwalde RD, Castranova V, et al. Occupational 
safety and health criteria for responsible development of nanotechnology. J Nanopart Res. 2014; 
16:2153.doi: 10.1007/5/1051-013-2153-9 [PubMed: 24482607] 
Schulte P, Geraci C, Zumwalde R, Hoover M, Kuempel E. Occupational risk management of 
engineered nanoparticles. J Occup Environ Hyg. 2008; 5:239–49. [PubMed: 18260001] 
Schulte PA, Hauser JE. The use of biomarkers in occupational health research, practice and policy. 
Toxicol Lett. 2012; 213:91–9. [PubMed: 21477643] 
Schulte PA, Schubauer-Berigan MK, Mayweather C, Geraci CL, Zumwalde R, Mc Kernan JL. Issues 
in the development of epidemiologic studies of workers exposed to engineered nanoparticles. J 
Occup Environ Med. 2009; 51:323–35. [PubMed: 19225418] 
Schulte P, Murashov V, Zumwalde R, Kuempel E, Geraci C. Occupational exposure limits for 
nanomaterials: state of the art. J Nanopart Res. 2010; 12:1971–87.
SER. Advisory Report 0901. Nanoparticles in the Workplace: Health and Safety Precautions. The 
Hague: Social and Economic Council of the Netherlands; 2009. 
Shvedova AA, Kisin ER, Mercer R, Murray AR, Johnson VJ, Potapovich AI, et al. Unusual 
inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am 
J Physiol-Lung Cell Mol Physiol. 2005; 289:L698–708. [PubMed: 15951334] 
Tran, C.; Donaldson, K.; Stones, V.; Fernandez, T.; Ford, A.; Christofi, N., et al. As Coping Study to 
Identify Hazard Data Needs for Addressing the Risks Presented by Nanoparticles and Nanotubes. 
Edinburgh, UK, London: Institute of Occupational Medicine; 2005. 
Schulte et al. Page 10














Number of nano-enabled products in commerce.
Schulte et al. Page 11














Cycle of steps to protect workers.
Schulte et al. Page 12














Pathways to risk management based on adequacy of data.
Schulte et al. Page 13














Relative counts of nanoparticles by size in a workplace exposure assessment.
Schulte et al. Page 14














Inclusion of safety earlier in the innovation process.
Schulte et al. Page 15

























Schulte et al. Page 16
Table 1
Precautionary guidance on ENMs by authoritative organizations.
Source Precautionary guidance on ENMs by authoritative organizations
Royal Society and The Royal 
Academy of Engineering 
(2004)
“We believe that chemicals in the form of nanoparticles and nanotubes should be treated separately to those in 
a larger form … while HSE performs a wider review of the adequacy of current regulation to assess and 
control workplace exposure … we have recommended that it consider setting lower occupational exposure 
levels …” p. 82
NIOSH (2005) “Given the limited amount of information about health risks that may be associated with nanomaterials, taking 
measures to minimize worker exposure is prudent.” p. vii
IRRST (Ostiguy, 2010) “Production and use of NM can signify different types of risks… It is essential that the senior management of 
every establishment makes OSH an action priority…” p. 63
“Given the current absence of standards and many uncertainties related to toxicity… it is recommended that a 
precautionary approach be adopted to NM production handling, storage, transportation and use control plans.” 
p. 69
BAuA (2007) “… it cannot be ruled out that exposure to nanomaterials might have specific effects different to the effects in 
the micrometer range … Until specific limit values are laid down for nanoparticles … it should therefore be 
striven to minimize exposure.” p. 5
Netherlands (SER, 2009) “The basic principles are that substances attended by uncertain or unknown risks which include nanoparticles 
– should be treated as hazardous (or extremely hazardous) substances.” p. 7 http://www.ser.nl/en/publications/
publications/2009/2009_01.aspx
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